Price target
Roughly €2,600 per adult, with a sensible tolerance above or below if the benefit trade-off is clear.
Revised 2021–2025 research · Ireland
This revised report is for a retired husband and wife, both 72, with no underlying health conditions. They want a plan near €2,600 per adult, inpatient excess around €100–€150, willingness to accept around 20% orthopaedic co-payment, hi-tech overnight shortfall up to €250/night, strong scan cover and good consultant outpatient refunds. They are Leinster-based and are specifically comparing Laya Prosper Advanced, Laya Excel Care and their previous Level Health Plan D.
Revised brief
Roughly €2,600 per adult, with a sensible tolerance above or below if the benefit trade-off is clear.
Ideal inpatient excess around €100–€150, although a lower excess is obviously acceptable if the premium is still good.
Orthopaedic co-payment around 20% and hi-tech overnight shortfall up to €250/night are acceptable.
Good direct-pay MRI/CT/PET cover and meaningful consultant outpatient refunds now matter more than in the first brief.
Interpretation: the best plan is not the richest plan. It is the plan that lands near budget while avoiding the big traps: no Blackrock/Mater exclusion, no very large nightly hi-tech shortfall, no 40% orthopaedic/ophthalmic shortfall unless the premium saving is compelling, and no weak scan/consultant outpatient benefits.
Revised recommendation
Premiums are annual per adult. Couple premium is simply double the adult price because Irish private health insurance is community-rated. Prices are the latest values captured from HIA/insurer data during this update; always confirm against the HIA comparison tool and the insurer table of benefits before switching.
€2,311.59 pp
Best value against the revised brief. It is cheaper than Excel Care, has the desired 20% specified orthopaedic/ophthalmic shortfall, only €175/night Blackrock/Mater hi-tech shortfall, 75% consultant refunds and a very high €7,650 outpatient limit.
€2,527.94 pp
The cleanest match to the couple’s stated tolerance: no inpatient excess, 20% specified orthopaedic/ophthalmic shortfall, Blackrock/Mater shortfall exactly at the €250/night ceiling, and excellent outpatient/scans.
€2,661.55 pp
Best VHI inpatient alternative: €100 claim excess, €200/night hi-tech accommodation excess and orthopaedic/ophthalmic procedures covered. Weakness: consultant outpatient refund is only €70/visit and GP cover is limited.
€2,563.55 pp
Good premium, excess, scan and outpatient profile, but now the major drawback is a 40% shortfall for specified orthopaedic/ophthalmic procedures. Excel Care or 360 Care Select look better for the revised brief.
Cost × feature coverage
Filter the table to compare providers or plan names. The “fit score” is a qualitative ranking for this exact couple: price near €2,600, inpatient excess near €100–€150, 20% orthopaedic tolerance, hi-tech overnight shortfall up to €250, direct scan cover and consultant outpatient value.
| Plan | Adult / couple premium | Inpatient excess | Hi-tech overnight terms | Orthopaedic / ophthalmic | Scans & consultant outpatient | Leinster hospital relevance | Fit |
|---|---|---|---|---|---|---|---|
| Laya 360 Care Select | €2,311.59 / €4,623.18 | €50 per claim; excess not payable for first claim per year. | Beacon: €50 excess. Blackrock/Mater: €50 excess plus €175/night shortfall. | 20% shortfall | Direct-pay MRI/CT/PET; radiology/pathology 75%; consultant 75% refund; €7,650 outpatient limit. | Strong Leinster fit: Beacon plus Blackrock/Mater access; verify full Laya hospital list for other private hospitals. | Best value. |
| Laya Excel Care | €2,527.94 / €5,055.88 | No inpatient excess shown in hospital wording; HIA inpatient excess field €0. | Beacon: covered. Blackrock/Mater: €250/night shortfall. | 20% shortfall | Direct-pay MRI/CT/PET; radiology/pathology 75%; first two consultant visits covered, then 75%; first two GP/nurse visits covered, then 75%; €7,650 limit. | Excellent Leinster fit for Beacon and acceptable Blackrock/Mater shortfall exactly at the stated ceiling. | Best match to stated tolerances. |
| VHI AdvancedCare 100 | €2,661.55 / €5,323.10 | €100 inpatient claim excess; private-room accommodation €50/night. | High-tech: €100 per claim plus €200/night accommodation. Day-case: €50. | Covered subject to normal excesses | Direct-pay MRI/CT/PET; consultant €70/visit subject to €100 annual excess; GP not covered except VHI 360 primary-care routes. | Strong inpatient access, but outpatient value is weaker than Laya for this couple. | Best inpatient-first alternative. |
| Laya Transform Advanced | €2,232.81 / €4,465.62 | €50 per claim in selected private hospitals; first claim waived. | Beacon included; Blackrock/Mater €200/night shortfall; first claim excess waived. | 20% shortfall | Direct-pay MRI/CT/PET; radiology/pathology 75%; consultant 75%; outpatient limit €1,500. | Good if selected hospital list is acceptable; the smaller outpatient limit is the main weakness versus 360 Care Select/Excel Care. | Best lower-cost alternative. |
| Laya Prosper Advanced | €2,563.55 / €5,127.10 | €100 overnight / €50 day-case; first claim per year not payable. | Beacon: €100 excess. Blackrock/Mater: €100 excess plus €175/night shortfall. | 40% shortfall | Direct-pay MRI/CT/PET; radiology/pathology 75%; consultant 75%; outpatient limit €2,000. | Good Leinster access, but the 40% joint/eye procedure exposure is high for age 72. | Current plan; switch likely worth exploring. |
| Level Health Plan D | €3,307.05 / €6,614.10 | €0 inpatient excess. | Private and high-tech hospitals covered. | €1,000 orthopaedic co-pay; €300 ophthalmic co-pay | Direct-pay MRI/CT/PET; consultant €150 x 4 visits, then €50 subject to outpatient excess; outpatient limit €3,000. | Very strong hospital comfort, but latest price is well above the €2,600 target. | Good but now expensive. |
| Laya Optimum Premium | €2,169.55 / €4,339.10 | €50; first claim not payable. | Beacon €50. Blackrock/Mater €150 excess plus €175/night shortfall. | 40% shortfall | Direct-pay MRI/CT/PET; radiology/pathology 75%; consultant 75%; €7,650 outpatient limit. | Good price and outpatient value, but 40% joint/eye shortfall makes it less suitable. | Budget option only. |
| Laya Evolve | €2,328.28 / €4,656.56 | €125 hospital excess. | Beacon €125. Blackrock/Mater €175 excess plus €325/night shortfall. | 20% shortfall | Direct-pay MRI/CT/PET; consultant 50% up to €125; outpatient limit €1,000. | Hi-tech nightly shortfall exceeds the couple’s €250/night tolerance. | Inferior to 360 Care Select / Excel Care. |
| Laya ConnectCare | €2,523.45 / €5,046.90 | €100 overnight / €75 day-case. | Beacon €100. Blackrock/Mater €250 excess plus €325/night shortfall. | 20% shortfall | Direct-pay MRI/CT/PET; consultant first visit covered then 50%; €7,650 limit. | Costs about Excel Care but has weaker Blackrock/Mater and outpatient terms. | Avoid versus Excel Care. |
| VHI AdvancedCare 250 | €2,588.91 / €5,177.82 | €250 claim excess; outside the preferred €100–€150 band. | High-tech: €250 per claim plus €200/night; day-case €125. | Covered subject to normal excesses | Direct-pay MRI/CT/PET; consultant €70/visit; weak GP/outpatient refunds versus Laya. | Good inpatient alternative if higher claim excess is acceptable. | Good price, wrong excess profile. |
| Laya 360 Care | €3,774.82 / €7,549.64 | €0 shown. | Beacon covered. Blackrock/Mater €100 excess plus €200/night shortfall. | 20% shortfall | Direct-pay MRI/CT/PET; consultant 75%; €7,650 limit. | Excellent, but substantially above budget. | Too expensive for this brief. |
Decision test
Prosper Advanced is not a bad plan. The issue is that two nearby Laya plans fit the revised constraints better.
| Move | Premium impact per adult | Main improvement | Main trade-off |
|---|---|---|---|
| Prosper Advanced → 360 Care Select | Save ~€251.96 | Orthopaedic/ophthalmic improves from 40% shortfall to 20%; outpatient limit increases from €2,000 to €7,650. | Hospital excess lower (€50) but confirm exact hospital list and renewal availability. |
| Prosper Advanced → Excel Care | Save ~€35.61 | Orthopaedic/ophthalmic improves from 40% to 20%; no inpatient excess; better first-visit outpatient refunds. | Blackrock/Mater overnight shortfall rises from €175 to €250/night. |
| Prosper Advanced → VHI AdvancedCare 100 | Pay ~€98.00 more | Orthopaedic/ophthalmic moves to covered with excess; high-tech accommodation €200/night. | Much weaker consultant/GP outpatient refunds than Laya. |
| Prosper Advanced → Level Plan D | Pay ~€743.50 more | Richer hospital comfort and clearer high-tech cover. | Now far above budget; orthopaedic €1,000 co-pay rather than 20% shortfall. |
Five-year data
Historical pricing is drawn from HIA price-change files gathered during research. Historical benefit wording is clearest for plans with HIA/insurer benefit PDFs; where a plan’s benefits have clearly drifted, this is noted. This table is a decision history, not a guarantee that the historical benefit still applies today.
| Year | Best-value pick | Approx adult price | Why it fit the brief | Caveat |
|---|---|---|---|---|
| 2021 | Laya 360 Care Select; late-year Laya Transform Advanced | 360 Care Select €1,929.01; Transform Advanced €1,790.00 at launch | Both were strong value versus older corporate plans; Transform Advanced launched with 20% orthopaedic/ophthalmic shortfall and Blackrock/Mater nightly shortfall well within the couple’s tolerance. | Transform launched at the end of 2021, so 360 Care Select was the practical mid-year pick. |
| 2022 | Laya Prosper Advanced or Transform Advanced | Prosper Advanced €2,130.00; Transform Advanced ~€1,790–€1,819 | Prosper Advanced launch/early wording was very strong, including full specified orthopaedic/ophthalmic cover in the HIA PDF; Transform Advanced was cheaper with a 20% shortfall. | Prosper Advanced’s current wording is weaker, so do not assume the 2022 benefit still applies. |
| 2023 | Laya 360 Care Select / VHI AdvancedCare 100 | 360 Care Select €2,014.81; VHI AC100 €1,967.07 | 360 Care Select better balanced outpatient/scans and the 20% orthopaedic tolerance; VHI AC100 was the better inpatient-only alternative. | VHI outpatient refunds remained weaker. |
| 2024 | Level Health Plan D at launch, or VHI AdvancedCare 100 | VHI AC100 €2,412.39; Level Plan D launch/pre-Apr-2025 price reported around €2,535.72 | Plan D matched the couple’s actual past choice: strong hospital comfort and good outpatient structure near the target price at launch. VHI AC100 was a strong fallback if Laya outpatient was less important. | Plan D repriced materially in 2025 and is now above target. |
| 2025 | Laya 360 Care Select / Laya Excel Care | Latest captured: 360 Care Select €2,311.59; Excel Care €2,527.94 | Both land below €2,600 and match the 20% orthopaedic tolerance. Excel Care is closest to the user’s stated interest; 360 Care Select is the value surprise. | Confirm renewal-date pricing and hospital-list terms before switching. |
“Latest captured” reflects current HIA/insurer data available during this update. Older price rows are from HIA notices and insurer filings. Plan names occasionally changed spacing, e.g. ExcelCare / Excel Care.
| Plan | 2021 | 2022 | 2023 | 2024 | 2025 / latest captured | Benefit trend |
|---|---|---|---|---|---|---|
| Laya 360 Care Select | €1,929.01 | €1,950.30 | €2,014.81 | — | €2,311.59 latest | Still one of the best fits: 20% specified joint/eye shortfall, €175/night Blackrock/Mater shortfall, strong outpatient. |
| Laya ExcelCare / Excel Care | €2,155.86 | €2,191.20 | — | — | €2,527.94 latest | Current Excel Care is highly aligned: no hospital excess, 20% specified joint/eye shortfall and strong consultant/scans. |
| Laya Prosper Advanced | — | €2,130.00 | €2,164.95 | — | €2,563.55 latest | Important deterioration: historical PDF showed full specified orthopaedic/ophthalmic cover; current HIA data shows 40% shortfall. |
| Laya Transform Advanced | €1,790.00 at launch | — | €1,819.85 | — | €2,232.81 latest | Still good value; current outpatient limit is lower (€1,500) and private-hospital wording says selected hospitals. |
| Laya Optimum Premium | — | €1,670.00 | €1,735.45 | — | €2,169.55 latest | Excellent price/outpatient but current 40% specified joint/eye shortfall is a major weakness. |
| VHI AdvancedCare 100 | — | €1,863.88 | €1,967.07 | €2,412.39 | €2,490.76 Mar-2025 / €2,661.55 latest | Inpatient cover stayed attractive; outpatient consultant refund is modest. |
| VHI AdvancedCare 250 | — | — | — | — | €2,250.00 launch / €2,588.91 latest | Good premium but €250 excess is outside the preferred €100–€150 band. |
| Level Health Plan D | — | — | — | Launched Nov 2024 | ~€2,535.72 pre-Apr-2025; €2,973.44 Apr-2025; €3,307.05 latest | Strong hospital plan, but repricing moved it away from the €2,600 target. |
Provider patterns
Laya has the strongest cluster around this revised brief: Excel Care, 360 Care Select, Transform Advanced and Prosper Advanced. The key is avoiding Laya plans where Blackrock/Mater is either excluded or has a high nightly shortfall, and avoiding 40% joint/eye shortfall where possible.
Current fit: best provider cluster.
VHI AdvancedCare 100 is excellent for inpatient/high-tech certainty, but the outpatient consultant and GP benefits are much weaker than the best Laya options. VHI is best if hospital exposure matters more than day-to-day outpatient refunds.
Current fit: best inpatient fallback.
Plan D was compelling near launch because it combined strong hospital cover with clear outpatient benefits. Its later pricing makes it less attractive for a €2,600 target, although it remains a useful benchmark.
Current fit: good cover, now expensive.
Many Irish Life plans near this price point use partial Blackrock/Mater percentages or material orthopaedic co-payments. Some have good outpatient limits, but the high-tech structure is less aligned than Laya 360/Excel or VHI AdvancedCare.
Current fit: not first choice.
The old strategy of choosing a corporate plan still helps only if the current benefit wording is checked. Several historically strong plans have drifted through higher prices, higher shortfalls or less generous orthopaedic wording.
Rule: check exact wording every year.
Trends & warnings
For age 72, a 40% specified orthopaedic/ophthalmic shortfall is a major exposure. This is the biggest reason Prosper Advanced is no longer the best fit despite its otherwise good profile.
Excel Care matches the stated tolerances very well. However, 360 Care Select appears to offer similar or better core risk terms at a lower premium, especially because its Blackrock/Mater shortfall is €175/night rather than €250/night.
If consultant and scan refunds matter, Laya 360 Care Select and Excel Care are more attractive than VHI AdvancedCare 100. VHI wins mainly on inpatient certainty and covered orthopaedic/ophthalmic benefits.
Plan D was attractive around launch / early 2025 near the couple’s budget. At the latest captured price above €3,300, it is a richer-cover benchmark rather than the best-value option.
“Covered” can still mean: excess plus nightly shortfall, percentage shortfall, selected-hospital limits or procedure-specific co-payments. The right comparison is expected patient exposure, not the word “covered”.
| Plan | 5-night Blackrock/Mater hi-tech stay | Joint/eye procedure exposure | Outpatient strength |
|---|---|---|---|
| Laya 360 Care Select | €50 claim excess + €175×5 = €925; first claim excess may be waived. | 20% specified shortfall. | Very strong: 75%, €7,650 limit. |
| Laya Excel Care | €250×5 = €1,250. | 20% specified shortfall. | Excellent: first 2 visits covered, then 75%, €7,650 limit. |
| VHI AdvancedCare 100 | €100 claim excess + €200×5 = €1,100. | Covered subject to normal excesses. | Moderate: €70/consultant visit. |
| Laya Prosper Advanced | €100 claim excess + €175×5 = €975; first claim excess may be waived. | 40% specified shortfall. | Strong: 75%, €2,000 limit. |
| Level Plan D | Standard high-tech covered. | €1,000 orthopaedic co-pay; €300 ophthalmic co-pay. | Good: €150 x 4 consultant visits, €3,000 limit. |
Before switching
Assumptions & caveats
Sources